More immunosuppressive, more immunotherapy responsive? A double-edged sword of HBV-induced immune response in HCC

Hepatology. 2023 Sep 1;78(3):706-708. doi: 10.1097/HEP.0000000000000393. Epub 2023 Apr 5.

Authors

Chien-Hao Huang¹, Sen-Yung Hsieh

Affiliation

¹ Department of Gastroenterology and Hepatology, Chang Gung Memorial Hospital, Linkou, Taoyuan, Taiwan.

PMID: 37013921
DOI: 10.1097/HEP.0000000000000393

No abstract available

Publication types

Comment

MeSH terms

Carcinoma, Hepatocellular* / therapy
Hepatitis B virus
Humans
Immunity
Immunosuppressive Agents / therapeutic use
Immunotherapy
Liver Neoplasms* / therapy

Substances

Immunosuppressive Agents